MILAN (AP) — Russia has signed a deal to produce its Sputnik V coronavirus vaccine in Italy, the first contract in the European Union, the Italian Russian Chamber of Commerce
JUNEAU, Alaska Gov. Mike Dunleavy says Alaska will become the first state to drop eligibility requirements and allow anyone 16 or older who lives or works in the state
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
PSI Awarded $8.8 Million U.S. Army Europe’s Installation Access Control Support Services Contract
Planned Systems International, Inc.March 9, 2021 GMT
ARLINGTON, Va., March 09, 2021 (GLOBE NEWSWIRE) Planned Systems International, Inc. (PSI) a leading provider of enterprise information technology (IT) solutions and services to the federal government announced today it has been awarded the Installation Access Control Support Services (IACSS) task order by the U.S. Army Europe (USAREUR) headquarters. The task order has a total estimated value of $8.8 million over a five-year period, inclusive of a 10-month base period and four one-year options.
Press release content from Business Wire. The AP news staff was not involved in its creation.
Elliptic Labs Expands to Taiwan and Signs Proof-of-Concept Contract With a New PC OEM
March 8, 2021 GMT
OSLO, Norway (BUSINESS WIRE) Mar 8, 2021
Continuing its strong push into the PC/laptop market, Elliptic Labs (EuroNext Growth: ELABS.OL) has expanded its team to Taiwan and signed a fifth Proof-of-Concept contract for its AI Virtual Presence Sensor, this time with another top-five PC manufacturer. This project will be done on an Intel Tiger Lake platform.
Elliptic Labs’ AI Virtual Presence Sensor is a software-only solution that automatically turns a laptop’s screen on and off based on whether a user is present in front of it or not. The virtual sensor does this by utilizing the laptop’s existing speaker and microphone to transmit and receive ultrasound signals, then interprets those signals using AI and proprietary algorithms to detect when a user enters or leaves the area.
Press release content from Business Wire. The AP news staff was not involved in its creation.
Exelixis Enters into Exclusive License Agreement with WuXi Biologics to Support Further Expansion of its Growing Oncology Biologics Pipeline
March 8, 2021 GMT
ALAMEDA, Calif. & SHANGHAI (BUSINESS WIRE) Mar 8, 2021
Exelixis, Inc. (Nasdaq: EXEL) and WuXi Biologics (“WuXi Bio”) (2269.HK) today announced the companies have entered into an exclusive license agreement to support the continued expansion of Exelixis’ oncology biologics pipeline. The agreement is the latest in a series of biologics-focused transactions for Exelixis as the company builds out its pipeline behind CABOMETYX ® (cabozantinib), its flagship product and global oncology franchise, which received its fourth approval from the U.S. Food and Drug Administration in January.